1323402-44-3

Upstream product

• 1323407-27-7 methyl 5-amino-5-oxo-4-(1-oxo-4-(4-(2-pyrrolidin-1-ylethoxy)benzyloxy)isoindolin-2-yl)pentanoate 
• 603-80-5 3-hydroxy 2-methylbenzoic acid 
• 55289-05-9 methyl 3-hydroxy-2-methylbenzoate 
• 359629-73-5 3-(tert-butyl-dimethyl-silanyloxy)-2-methyl-benzoic acid methyl ester 
• 1323407-17-5 2-bromomethyl-3-(tert-butyl-dimethyl-silanyloxy)-benzoic acid methyl ester 
• 1323407-16-4 4-carbamoyl-4-(4-hydroxy-1-oxo-1,3-dihydro-isoindol-2-yl)-butyric acid methyl ester 
• 262425-92-3 (4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)methanol 
• 123-08-0 4-hydroxy-benzaldehyde 
• 26116-47-2 4-(2-tetrahydro-1H-1-pyrrolylethoxy)benzaldehyde 

Relevant academic research and scientific papers

METHODS FOR THE TREATMENT OF LOCALLY ADVANCED BREAST CANCER

Provided herein are methods of treating, preventing and/or managing locally advanced breast cancer, including inflammatory breast cancer, which comprise administering to a patient one or more immunomodulatory compounds or enantiomers or mixtures of enantiomers thereof, or pharmaceutically acceptable salts, solvates, hydrates, co-crystals, clathrates, or polymorphs thereof.

Arylmethoxy Isoindoline Derivatives and Compositions Comprising and Methods of Using the Same

Provided are 4′-arylmethoxy isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.